Sramana Mitra: The lifetime value of the customer is much higher. Prashant Warier: I don’t think we have had more than one or two churn. That means a lot to me. The lifetime value is high. Also, it takes time to activate a market. Once there is a reasonable number of users in a certain
Sramana Mitra: When did you enter the US? Before of after the Sequoia funding? Prashant Warier: Just before the Sequoia funding, we hired our Chief Commercial Officer, but we didn’t have FDA clearance. FDA clearance came in 2021. Our real traction was in 2022. Even now, we are very small in the US. We have
Sramana Mitra: When you validated the TB use case in 2018, did you put that as your only use case? Were you doing other radiology use cases as well? Prashant Warier: We had a lot of other use cases. We are also working on a head CT product. Chest X-rays has a high volume. The
Sramana Mitra: How did you find this customer? Prashant Warier: TB is not one of those things that you can identify on an X-ray. If there is TB, it is likely that the X-ray will show some abnormality, but not every abnormality is likely to be TB. It could be other kinds of disease. Even
Sramana Mitra: How long did it take you to build a product based on this data? Prashant Warier: We started in 2016 — a lot of the data acquisition happened by mid-2017. In the first year of Qure, I was on the road working on getting more data. As a data scientist, I knew that
Sramana Mitra: What happened to the company? Prashant Warier: I got an exit in 2015. Somebody wanted to acquire the technology and use that for customer targeting for email engines. Sramana Mitra: Was that bootstrapped? Prashant Warier: Yes.
Prashant has built a wonderful Healthcare AI company with 1600 customers worldwide. This is extremely sophisticated navigation. Please read on to learn the nuances. Sramana Mitra: Let’s start at the very beginning of your journey. Where are you from? Where were you born and raised? What kind of background?
Sramana Mitra: Your friend gave you some money and gave the money back. What other financing has happened? Ankush Sabharwal: My two friends who joined as co-founders gave me money. We took angel funding just before IRCTC went live. Then we got funds from Canbank VC. Now we will be announcing a fund raise. Sramana